» Articles » PMID: 25213006

Copeptin and Arginine Vasopressin at High Altitude: Relationship to Plasma Osmolality and Perceived Exertion

Overview
Specialty Physiology
Date 2014 Sep 13
PMID 25213006
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: A diuresis is a key part of acclimatisation to high altitude (HA). Arginine vasopressin (AVP) is a hormone involved in salt and water balance and may potentially have a role in the development of altitude illness. ProAVP (copeptin) is more stable than AVP and is assayed by a straightforward, automated method. We investigated the relationship of AVP to copeptin and the copeptin response to exercise and altitude illness in a large cohort during a field study at HA.

Methods: 48 subjects took part in a 10-day trek at HA. Venous blood samples were taken at 3,833, 4,450 and 5,129 m post-trek (exercise) and the following day at rest. Daily recordings of symptoms of altitude illness, oxygen saturations and perceived exertion were carried out.

Results: AVP and copeptin levels increased with exercise and correlated closely (ρ 0.621 p < 0.001), this was strongest in the stressed state when AVP secretion was highest, at 5,129 m post-exercise (ρ 0.834 p < 0.001). On two-way ANOVA, both altitude (F = 3.5; p = 0.015) and exercise (F = 10.2; p = 0.002) influenced copeptin levels (interaction F = 2.2; p = 0.08). AVP levels were influenced by exercise (F = 14.4; p = 0.0002) but not altitude (F = 2.0; p = 0.12) with no overall group interactions (F = 1.92.6; p = 0.06). There was no association between copeptin or arginine vasopressin and altitude illness. Copeptin correlated with the Borg RPE score and was significantly higher in the group with a Borg score ≥15 (7.9 vs. 3.7 p < 0.001).

Conclusion: We have shown that arginine vasopressin and copeptin levels correlate and are suppressed below 5,129 m. Furthermore, we have demonstrated that exertion, rather than altitude illness or increasing osmolality, is the stimulus for increases in copeptin.

Citing Articles

Incidence of exercise-associated hyponatremia during a high-altitude 161-km ultramarathon.

Khodaee M, Saeedi A, Harris-Spinks C, Hew-Butler T Phys Act Nutr. 2021; 25(3):16-22.

PMID: 34727684 PMC: 8580585. DOI: 10.20463/pan.2021.0016.


Heat acclimatization blunts copeptin responses to hypertonicity from dehydrating exercise in humans.

Stacey M, Woods D, Brett S, Britland S, Fallowfield J, Allsopp A Physiol Rep. 2018; 6(18):e13851.

PMID: 30221840 PMC: 6139708. DOI: 10.14814/phy2.13851.


Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy.

Czarzasta K, Cudnoch-Jedrzejewska A, Niemczyk L, Wrzesien R, Tkaczyk M, Puchalska L Biomed Res Int. 2018; 2018:2607928.

PMID: 30013980 PMC: 6022316. DOI: 10.1155/2018/2607928.


Copeptin reflects physiological strain during thermal stress.

Stacey M, Delves S, Britland S, Allsopp A, Brett S, Fallowfield J Eur J Appl Physiol. 2017; 118(1):75-84.

PMID: 29075863 PMC: 5754412. DOI: 10.1007/s00421-017-3740-8.


Serum NGAL and copeptin levels as predictors of acute kidney injury in asphyxiated neonates.

Baumert M, Surmiak P, Wiecek A, Walencka Z Clin Exp Nephrol. 2016; 21(4):658-664.

PMID: 27590891 PMC: 5517581. DOI: 10.1007/s10157-016-1320-6.


References
1.
Burd J, Weightman D, Spruce B, Baylis P . A solid phase radioimmunoassay for human plasma arginine vasopressin. Clin Chim Acta. 1984; 136(2-3):251-6. DOI: 10.1016/0009-8981(84)90300-0. View

2.
Morgenthaler N, Struck J, Jochberger S, Dunser M . Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab. 2008; 19(2):43-9. DOI: 10.1016/j.tem.2007.11.001. View

3.
Hew-Butler T, Hoffman M, Stuempfle K, Rogers I, Morgenthaler N, Verbalis J . Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia. Clin J Sport Med. 2011; 21(3):211-7. PMC: 3690462. DOI: 10.1097/JSM.0b013e31821a62c2. View

4.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R . European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by.... Eur J Cardiovasc Prev Rehabil. 2007; 14 Suppl 2:S1-113. DOI: 10.1097/01.hjr.0000277983.23934.c9. View

5.
Westermann I, Dunser M, Haas T, Jochberger S, Luckner G, Mayr V . Endogenous vasopressin and copeptin response in multiple trauma patients. Shock. 2007; 28(6):644-649. DOI: 10.1097/shk.0b013e3180cab33f. View